This inventor holds 1 USPTO granted patent. Top assignee: National Health Research Institutes. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: The Innovative Contributions of Po-Kuan Chao
Introduction
Po-Kuan Chao is a distinguished inventor based in Miaoli County, Taiwan, known for his significant contributions to the field of pharmaceutical sciences. With a focus on developing novel compounds, Chao has made strides in addressing opioid receptor-associated conditions, which are crucial in today’s medical landscape.
Latest Patents
Chao holds a patent for "Tetrahydroisoquinolines for use as MOR/NOP dual agonists." This patent discloses compounds of a specific formula, including pharmaceutically acceptable salts. The innovation also includes a method for treating conditions associated with opioid receptors using these compounds, alongside pharmaceutical compositions that comprise them. This significant development highlights Chao's commitment to improving healthcare solutions.
Career Highlights
Po-Kuan Chao is currently affiliated with the National Health Research Institutes, where he continues to contribute to health-related innovations. His dedication to research and development has positioned him as a valuable asset in the field of pharmacology and therapeutics.
Collaborations
Chao collaborates with notable colleagues, including Shau-Hua Ueng and Shiu-Hwa Yeh, reflecting a synergistic approach to research and innovation. These collaborations enable the sharing of ideas and expertise, fostering an environment conducive to groundbreaking discoveries.
Conclusion
In conclusion, Po-Kuan Chao's work illustrates the impact of innovative thinking in addressing challenging medical issues. His patent for Tetrahydroisoquinolines showcases the potential for new therapies aimed at opioid receptor-associated conditions, underscoring the importance of continued research and collaboration in the scientific community.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
